Award Winners

The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations at ISPOR's conferences. ISPOR Judges evaluated podium and poster presentations within the top 5% of accepted abstracts, which were based on abstract peer reviewed scores, and were eligible for a presentation award. Evaluations of scientific merit were based upon the following criteria:

QUALITY OF RESEARCH STUDY

  • Research design is appropriate and transparent
  • Data sources are appropriate and transparent
  • Data analyses are appropriate and transparent
  • Results are included and are transparent and comprehensible
  • Uncertainty of results is addressed appropriately
  • Conclusions are consistent with the results

QUALITY OF PRESENTATION

  • Objectives/research questions are clearly stated, and objectives are addressed
  • Factual information is kept separate from interpretations or implications / unbiased presentations
  • Implications, as presented, are easy to understand
  • Clarity of presentation

Click through for more information on the criteria used for judging Podiums and Posters.
 

THE RECIPIENTS ARE…


BEST GENERAL POSTER RESEARCH PRESENTATIONS

EE160: Tepotinib for the Treatment of Adult Patients with Metastatic Non-Small Cell Lung Cancer Harboring METEX14 Skipping Alterations: A US Cost-Effectiveness Analysis
Presenting Author: Mo Yang, EMD Serono, USA

EE312: The Economic Burden of Moderate-to-Severe Ulcerative Colitis in the EU5
Presenting Author: Jinender Kumar, Bristol Myers Squibb, USA

SA15: Real-World Calibration of the Disease Recovery Evaluation and Modification (DREaM) Randomized Clinical Trial in Adult Medicaid Beneficiaries With Recent-Onset Schizophrenia
Presenting Author: Charmi A. Patel, Janssen Scientific Affairs, LLC, USA


BEST STUDENT POSTER RESEARCH PRESENTATIONS

EE44: Cost-Effectiveness of Pembrolizumab in First-Line Treatment of PD-L1 Positive Persistent, Recurrent, or Metastatic Cervical Cancer
Presenting Author: Justin Nedzesky, University of Washington, USA

HSD6: Comparing Change in Medical Expenditure for Type 2 Diabetes Mellitus Patients with High Versus Low Adherence to Treatment Guidelines: A Retrospective Longitudinal Propensity Score-Matched Analysis
Presenting Author: Benjamin Lewing, University of Houston, College of Pharmacy, USA

HSD125: Geographic Variation of High-Risk Prescription Opioid Use Measures Among Disabled Medicare Beneficiaries, 2011-2018
Presenting Author: Motomori Lewis, University of Florida, USA

BEST NEW INVESTIGATOR POSTER RESEARCH PRESENTATIONS

HTA70: Forecasting Drug Price for Reimbursement By Utilizing a Value-Price Relationship, a Case Study in Hormone-Relapsed Prostate Cancer
Presenting Author: Sevcan Cigerli, Global Pricing Innovations, UK

EPH2: Adverse Outcomes Associated with Concurrent Gabapentin, Opioid, and Benzodiazepine Utilization: A Nested Case-Control Study
Presenting Author: Abisola Olopoenia, Cerner Enviza, USA

PCR127: Associations between Quality of Life, Major Depressive Disorder, Social Support, and Race/Ethnicity: A Moderation Analysis Using the 2021 US National Health and Wellness Survey
Presenting Author: Kathryn Krupsky, Cerner Enviza, USA

BEST GENERAL PODIUM RESEARCH PRESENTATIONS

P53: Patient Preferences for Multiple Myeloma Treatment: A Stated Preference Survey Using Discrete Choice Experiment and Swing Weighting
Presenting Author: Rosanne Janssens, KU Leuven, Belgium

P54: Patient Preferences for Treatment of BCG-Unresponsive Non-Muscle Invasive Bladder Cancer: A Discrete Choice Experiment
Presenting Author: Hannah Collacott, Evidera, UK

P65: Cost-Effectiveness of Every Two Month Cabotegravir Long-Acting (CAB-LA) Compared with Daily Oral Emtricitabine (FTC)/Tenofovir Disoproxil Fumarate (TDF) for PRE-Exposure Prophylaxis (PREP) to Prevent HIV-1 Infection in the United States
Presenting Author: Ashley Davis, RTI Health Solutions, USA

BEST STUDENT PODIUM RESEARCH PRESENTATIONS

P64: Cost-Utility Analysis Comparing Mastectomy and Lumpectomy in Early Stage Breast Cancer Surgeries in Sweden - a Life-Time Approach Using Markov Modelling
Presenting Author: Phu Duy Pham, Umea University, Sweden

P72: Designing a Value-Based Formulary for Kaiser Permanente Washington: A Hypothetical Case Study of Diabetes Mellitus Medications
Presenting Author: Yilin Chen, Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, USA

P25: Income and Equity Effect of Modelled Sugar Tax and Fruit and Vegetable Subsidy Program across Different Income Groups in Canada
Presenting Author: Siyuan Liu, University of Alberta, Canada

BEST NEW INVESTIGATOR PODIUM RESEARCH PRESENTATIONS

P37: A Comparison of the Newly Developed EQ-HWB-S to the ASCOT and EQ-5D-5L as an Outcome Measure for Caregivers
Presenting Author: Maja Kuharic, University of Illinois at Chicago, USA

P61: Cost Utility Analysis of Circulating Tumour DNA Guided Adjuvant Chemotherapy in Stage II Colon Cancer
Presenting Author: Yat Hang To, Walter and Eliza Hall Institute of Medical Research, Australia

P3: An Assessment of Barriers to Fair Access to Cost-Effective Drugs
Presenting Author: Molly Beinfeld, Institute for Clinical and Economic Review, USA